SightfileU.S. market data from official filings

GLOBUS MED INC (GMED)

Name: GLOBUS MED INC (GMED) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001237831 · EDGAR filings · Updated 2026-07-28

GLOBUS MED INC (GMED) has 600 institutional managers reporting positions valued at $9.42B per the latest 13F reporting period.

Institutional managers

600

Reported 13F value

$9.42B

Insider activity

24 trans.

−$11.7M net selling

Filings this week (1)

2026-07-28 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-06-09 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-05 — Notice of proposed sale filed (Form 144)
2026-06-04 — Current report (8-K) filed
2026-05-27 — SD filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GLOBUS MED INC has 600 institutional holders.

Insider activity

Insiders reported 24 transactions (0 buys, 12 sells) across 7 reporting insiders, with a net reported value of −$11.7M.

Related companies

DAVITA INC (DVA) · MASIMO CORP (MASI) · VAXCYTE INC (PCVX) · ENCOMPASS HEALTH CORP (EHC) · BIO-TECHNE CORP (TECH) · BRIGHTSPRING HEALTH SVCS INC (BTSG)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.